Literature DB >> 3485470

Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience.

S M Steinberg, J S Barkin, R S Kaplan, D M Stablein.   

Abstract

This study sought to replicate and expand findings reported by the National Surgical Adjuvant Breast and Bowel Project (NSABP) on prognostic factors in resectable colon cancer. Mantel-Haenszel tests and the Cox model were used to analyze prognostic significance and effect of primary disease symptoms and tumor location in 572 patients from the Gastrointestinal Tumor Study Group (GITSG), with resected Dukes' B2 and C colon cancer. Tumor location (left, right, and rectosigmoid/sigmoid) was of low prognostic importance (P greater than 0.10), and did not effect survival or disease-free survival (P greater than 0.10). Obstruction was an important indicator of prognosis, independent of Dukes' stage (P = 0.03). Bowel perforation is associated with poor prognosis in disease-free survival (P = 0.001). Rectal bleeding had a positive impact on survival (P = 0.08). Thus, obstruction, perforation, and rectal bleeding (but not location) are found to be prognostic factors in patients with Dukes' B2 or C colon cancer.

Entities:  

Mesh:

Year:  1986        PMID: 3485470     DOI: 10.1002/1097-0142(19860501)57:9<1866::aid-cncr2820570928>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  36 in total

1.  p27 cell-cycle inhibitor is inversely correlated with lymph node metastases in right-sided colon cancer.

Authors:  D F Liu; K Ferguson; G S Cooper; W M Grady; J Willis
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  miR-15a-5p, A Novel Prognostic Biomarker, Predicting Recurrent Colorectal Adenocarcinoma.

Authors:  Christos K Kontos; Panagiotis Tsiakanikas; Margaritis Avgeris; Iordanis N Papadopoulos; Andreas Scorilas
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

4.  Colonic self-expanding metal stent (SEMS) as a bridge to surgery in left-sided malignant colonic obstruction: an 8-year review.

Authors:  Kit-Man Ho; Ka-Man Chan; Shu-Yan Kwok; Patrick Ying-Yu Lau
Journal:  Surg Endosc       Date:  2016-09-08       Impact factor: 4.584

5.  Expression of cyclin E in stage III colorectal carcinoma.

Authors:  Lea Rath-Wolfson; Michael Bergman; Yaacov Ori; Alex Goldman; Edward Ram; Rumelia Koren; Hertzel Salman
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

6.  Adjuvant Chemotherapy for Stage II Colon Cancer: The Role of Molecular Markers in Choosing Therapy.

Authors:  Patrick Chun; Zev A Wainberg
Journal:  Gastrointest Cancer Res       Date:  2009-09

Review 7.  Pathologic prognostic factors for gastrointestinal cancer.

Authors:  T Ismail; M T Hallissey; J W Fielding
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

Review 8.  The Worse Prognosis of Right-Sided Compared with Left-Sided Colon Cancers: a Systematic Review and Meta-analysis.

Authors:  Masashi Yahagi; Koji Okabayashi; Hirotoshi Hasegawa; Masashi Tsuruta; Yuko Kitagawa
Journal:  J Gastrointest Surg       Date:  2015-11-16       Impact factor: 3.452

9.  Quantitative expression analysis and prognostic significance of L-DOPA decarboxylase in colorectal adenocarcinoma.

Authors:  C K Kontos; I N Papadopoulos; E G Fragoulis; A Scorilas
Journal:  Br J Cancer       Date:  2010-04-27       Impact factor: 7.640

10.  Insufficient Lymph Node Sampling in Patients with Colorectal Cancer Perforation is Associated with an Adverse Oncological Outcome.

Authors:  Kotaro Sugawara; Yoshikuni Kawaguchi; Yukihiro Nomura; Daisuke Koike; Motoki Nagai; Nobutaka Tanaka
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.